Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
1 to 21 of 21  Show

Literature citations Results

The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis.

Tsai M.K., Ho H.N., Chien H.F., Ou-Yang P., Lee C.J., Lee P.H.

Transplantation 77:48-54(2004) · Mapped (19)

The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.

Goldwurm S., Di Fonzo A., Simons E.J., Rohe C.F., Zini M., Canesi M., Tesei S., Zecchinelli A., Antonini A., Mariani C. et al.

J. Med. Genet. 42:E65-E65(2005) · UniProtKB (1) · Mapped (4)

Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.

Johansson G., Peng P.C., Huang P.Y., Chien H.F., Hua K.T., Kuo M.L., Chen C.T., Lee M.J.

PLoS ONE 9:e115916-e115916(2014) · Mapped (3)

PRKAR1B mutation associated with a new neurodegenerative disorder with unique pathology.

Wong T.H., Chiu W.Z., Breedveld G.J., Li K.W., Verkerk A.J., Hondius D., Hukema R.K., Seelaar H., Frick P., Severijnen L.A. et al.

Brain 137:1361-1373(2014) · Mapped (5)

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

International LRRK2 Consortium
Healy D.G., Falchi M., O'Sullivan S.S., Bonifati V., Durr A., Bressman S., Brice A., Aasly J., Zabetian C.P., Goldwurm S. et al.

Lancet Neurol 7:583-590(2008) · Mapped (5)

Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency.

Olgiati S., Skorvanek M., Quadri M., Minneboo M., Graafland J., Breedveld G.J., Bonte R., Ozgur Z., van den Hout M.C., Schoonderwoerd K. et al.

Mov. Disord. 31:1041-1048(2016) · Mapped (2)

Olfactory heterogeneity in LRRK2 related Parkinsonism.

Silveira-Moriyama L., Munhoz R.P., de J Carvalho M., Raskin S., Rogaeva E., de C Aguiar P., Bressan R.A., Felicio A.C., Barsottini O.G., Andrade L.A. et al.

Mov. Disord. 25:2879-2883(2010) · Mapped (5)

Mutations in TMEM230 are not a common cause of Parkinson's disease.

Quadri M., Breedveld G.J., Chang H.C., Yeh T.H., Guedes L.C., Toni V., Fabrizio E., De Mari M., Thomas A., Tassorelli C. et al.

Mov. Disord. 32:302-304(2017) · Mapped (2)

Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset Parkinsonism.

Quadri M., Fang M., Picillo M., Olgiati S., Breedveld G.J., Graafland J., Wu B., Xu F., Erro R., Amboni M. et al.

Hum. Mutat. 34:1208-1215(2013) · UniProtKB (1) · Mapped (18)

Multiple negative feedbacks on CD152 expression in allograft tolerance.

Tsai M.K., Ho H.N., Chien H.F., Tzeng M.C., Chen C.H., Lee P.H.

Transplantation 79:174-181(2005) · Mapped (6)

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.

Italian Parkinson Genetics Network
Di Fonzo A., Fabrizio E., Thomas A., Fincati E., Marconi R., Tinazzi M., Breedveld G.J., Simons E.J., Chien H.F., Ferreira J.J. et al.

Parkinsonism Relat. Disord. 15:703-705(2009) · UniProtKB (1) · Mapped (4)

Ganoderma lucidum polysaccharides prevent platelet-derived growth factor-stimulated smooth muscle cell proliferation in vitro and neointimal hyperplasia in the endothelial-denuded artery in vivo.

Wang S.H., Liang C.J., Weng Y.W., Chen Y.H., Hsu H.Y., Chien H.F., Tsai J.S., Tseng Y.C., Li C.Y., Chen Y.L.

J. Cell. Physiol. 227:3063-3071(2012) · Mapped (8)

Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson's disease.

Chien H.F., Figueiredo T.R., Hollaender M.A., Tofoli F., Takada L.T., Pereira L.d.a. V., Barbosa E.R.

Arq Neuropsiquiatr 72:356-359(2014) · Mapped (5)

Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

The Italian Parkinson genetics network
Bonifati V., Rohe C.F., Breedveld G.J., Fabrizio E., De Mari M., Tassorelli C., Tavella A., Marconi R., Nicholl D.J., Chien H.F. et al.

Neurology 65:87-95(2005) · UniProtKB (1)

DNAJC6 mutations associated with early-onset Parkinson's disease.

International Parkinsonism Genetics Network
Olgiati S., Quadri M., Fang M., Rood J.P., Saute J.A., Chien H.F., Bouwkamp C.G., Graafland J., Minneboo M., Breedveld G.J. et al.

Ann. Neurol. 79:244-256(2016) · UniProtKB (3) · Mapped (1)

Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.

Di Fonzo A., Tassorelli C., De Mari M., Chien H.F., Ferreira J., Rohe C.F., Riboldazzi G., Antonini A., Albani G., Mauro A. et al.

Eur. J. Hum. Genet. 14:322-331(2006) · UniProtKB (1) · Mapped (4)

CD40-mediated HIF-1alpha expression underlying microangiopathy in diabetic nerve pathology.

Kan H.W., Hsieh J.H., Chien H.F., Lin Y.H., Yeh T.Y., Chao C.C., Hsieh S.T.

Dis Model Mech 11:0-0(2018) · Mapped (16)

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Di Fonzo A., Chien H.F., Socal M., Giraudo S., Tassorelli C., Iliceto G., Fabbrini G., Marconi R., Fincati E., Abbruzzese G. et al.

Neurology 68:1557-1562(2007) · UniProtKB (1) · Mapped (3)

Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells.

Lin S.J., Hsieh F.Y., Chen Y.H., Lin C.C., Kuan I.I., Wang S.H., Wu C.C., Chien H.F., Lin F.Y., Chen Y.L.

Histol. Histopathol. 24:1147-1159(2009) · Mapped (2)

A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.

The Italian Parkinson genetics network
Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N. et al.

Lancet 365:412-415(2005) · UniProtKB (1) · Mapped (4)

5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase.

Ji H.T., Chien L.T., Lin Y.H., Chien H.F., Chen C.T.

Mol. Cancer 9:91-91(2010) · Mapped (1)

1 to 21 of 21  Show
UniProt is an ELIXIR core data resource
Main funding by: National Institutes of Health

We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.

Do not show this banner again